Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Embolism × 1 year × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Breast Neoplasms 609 Neoplasms 571 Prostatic Neoplasms 297 Lung Neoplasms 270 Carcinoma, Non-Small-Cell Lung 244 Colorectal Neoplasms 239 Carcinoma, Hepatocellular 159 Pancreatic Neoplasms 155 Multiple Myeloma 119 Stomach Neoplasms 117 Ovarian Neoplasms 107 Hematologic Neoplasms 104 Melanoma 103 Colonic Neoplasms 103 Brain Neoplasms 97 Urinary Bladder Neoplasms 91 Esophageal Neoplasms 90 Leukemia, Myeloid, Acute 87 Head and Neck Neoplasms 87 Neoplasm Metastasis 83 Lymphoma 82 Uterine Cervical Neoplasms 81 Carcinoma, Renal Cell 79 Liver Neoplasms 77 Endometrial Neoplasms 77 Disease 77 Precursor Cell Lymphoblastic Leukemia-Lymphoma 74 Rectal Neoplasms 70 Leukemia 62 Glioma 60

Interventions

edoxaban 1 apixaban 1 Rivaroxaban 1 Heparin, Low-Molecular-Weight 1 Dabigatran 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04618913 2026-03-12

VICTORIE

Pfizer

Active not recruiting

Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡